MultiCASE, Inc. Information

We are proud to be a leading provider of AI-based software, expert systems, and in silico consulting for regulatory agencies, academia, and the chemical and pharmaceutical industries. Founded in 1996 by Dr. Giles Klopman and colleagues from Case Western Reserve University, we have been at the forefront of chemical entity design and early-stage toxicity evaluation. Our predictive toxicology software, trusted by regulatory agencies, pharma, and chemical companies, supports ICH M7 Step 2 compatible in silico toxicity assessments of drug candidates, impurities, and more. Backed by data from the FDA and endorsed by various regulatory agencies, MultiCASE is dedicated to advancing science and technology for a safer, sustainable future.